Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland

Por Martikainen, Jaana E, Maljanen, Timo, Koskinen, Hanna, Vogler, Sabine
Publicado no J Pharm Policy Pract (2015)

The impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in Finland

Por Koskinen, Hanna, Ahola, Elina, Saastamoinen, Leena K, Mikkola, Hennamari, Martikainen, Jaana E
Publicado no Health Econ Rev (2014)

Chronic Comorbidities Contribute to the Burden and Costs of Persistent Asthma

Por Kauppi, Paula, Linna, Miika, Jantunen, Juha, Martikainen, Jaana E., Haahtela, Tari, Pelkonen, Anna, Mäkelä, Mika
Publicado no Mediators Inflamm (2015)

Use of drugs for ADHD among adults—a multinational study among 15.8 million adults in the Nordic countries

Por Karlstad, Øystein, Zoëga, Helga, Furu, Kari, Bahmanyar, Shahram, Martikainen, Jaana E, Kieler, Helle, Pottegård, Anton
Publicado no Eur J Clin Pharmacol (2016)

Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications

Por Godman, Brian, Shrank, William, Andersen, Morten, Berg, Christian, Bishop, Iain, Burkhardt, Thomas, Garuoliene, Kristina, Herholz, Harald, Joppi, Roberta, Kalaba, Marija, Laius, Ott, Lonsdale, Julie, Malmström, Rickard E., Martikainen, Jaana E., Samaluk, Vita, Sermet, Catherine, Schwabe, Ulrich, Teixeira, Inês, Tilson, Lesley, Tulunay, F. Cankat, Vlahović-Palčevski, Vera, Wendykowska, Kamila, Wettermark, Bjorn, Zara, Corinne, Gustafsson, Lars L.
Publicado em 2011